The effect of GLP-1 receptor agonist use on negative evaluations of women with higher and lower body weight

Background Glucagon-like-peptide-1 receptor agonists (GLP-1s) are a newer class of obesity medications that have garnered significant attention by the public and media. Media reports suggest that medical interventions such as GLP-1s are often perceived as weight loss “shortcuts.” Purpose The present experimental research tested the effect of exposure to medical weight loss interventions on GLP-1 policy support, dependent on body mass index. Methods A sample of 440 participants (Mage = 37, SD = 12.6) were randomly assigned to read about a woman who lost 15% of her body weight either with a GLP-1, bariatric surgery, or diet/exercise. Participants reported on beliefs that the woman took a weight loss “shortcut” and support for three policies expanding GLP-1 coverage. Results Exposure to a woman who lost weight with GLP-1 or bariatric surgery (vs. diet/exercise) led to higher GLP-1 policy support. However, such exposure was also indirectly associated with lower policy support, partially mediated by weight loss “shortcut” beliefs. Conclusions This study provides evidence that exposure to medical weight loss interventions leads to higher GLP-1 policy support. Exposure may also, indirectly, lead to lower policy support due to beliefs that such interventions are shortcuts. Findings have implications for policymakers who are interested in how perceptions of medical weight loss interventions influence support for obesity treatments and related health policies.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The effect of GLP-1 receptor agonist use on negative evaluations of women with higher and lower body weight

Cited by 5 publications

References 31 publications

Weight Stigma

Weight Stigma

The Unintended Psychosocial Consequences of GLP-1 Receptor Agonists for Children and Adolescents: A Call for More Research

Exposure to GLP-1 Receptor Agonist and Bariatric Surgery Use on Obesity Policy Support

Contact Info

Product

Resources

About